Inspira Technologies Oxy B.H.N. Ltd. (IINN) has released an update.
Inspira Technologies Oxy B.H.N. Ltd. has announced a significant collaboration with Beilinson Hospital, Israel’s leading organ transplant center, to evaluate the company’s INSPIRA ART100 medical device in organ transplant procedures. The evaluation will include collecting data and feedback from medical professionals with the aim of potentially enhancing patient outcomes in organ transplants. This partnership underscores Inspira’s commitment to innovation and could represent a pivotal moment in advancing patient care within the organ transplant sector.
For further insights into IINN stock, check out TipRanks’ Stock Analysis page.
